iBio prices $50M public offering

* iBio (NASDAQ:IBIO [https://seekingalpha.com/symbol/IBIO]) announced a $50M underwritten public offering.
* The offering includes 71.54M pre-funded warrants and Series G and H warrants to purchase a total of 71.54M shares.
* Each unit (1 pre-funded warrant + 1 Series G warrant + 1 Series H warrant) is priced at $0.699. Series G and H warrants have an exercise price of $0.70 per share and various expiration terms tied to trial milestones.
* The offering is expected to close on or around August 22, 2025.
* Proceeds will fund development of cardiometabolic candidates IBIO-610 and IBIO-600, other preclinical assets, and general corporate purposes.
* Additional $50M could be raised if all Series G and H warrants are exercised in cash.
* IBIO shares down 3% premarket on Tuesday.
* Source: Press release [https://seekingalpha.com/pr/20204838-ibio-announces-pricing-of-50-million-public-offering]

MORE ON IBIO

* iBio drops on proposed public offering [https://seekingalpha.com/news/4486728-ibio-drops-on-proposed-public-offering]
* Seeking Alpha’s Quant Rating on iBio [https://seekingalpha.com/symbol/IBIO/ratings/quant-ratings]
* Historical earnings data for iBio [https://seekingalpha.com/symbol/IBIO/earnings]
* Financial information for iBio [https://seekingalpha.com/symbol/IBIO/income-statement]